BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 31403943)

  • 1. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
    Jin W; Han H; Liu D
    Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
    Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
    Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer.
    Li Y; Liu Y; Yao J; Li R; Fan X
    Diagn Pathol; 2020 Mar; 15(1):25. PubMed ID: 32192507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
    Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
    Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y; Xiao W; Jiang X; Li H
    Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression.
    Lv J; Zhang H; Gao Z; Zhang X; Huang X; Jia X
    Cancer Biomark; 2020; 28(2):247-254. PubMed ID: 32390603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-643 Functions as a Potential Tumor Suppressor in Gastric Cancer by Inhibiting Cell Proliferation and Invasion
    Wu Y; Ye H; Peng B; Jiang H; Tang Q; Liu Y; Xi J; Chen S
    Ann Clin Lab Sci; 2021 Jul; 51(4):494-502. PubMed ID: 34452887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-3178 as a prognostic indicator and tumor suppressor of gastric cancer.
    Wu JC; Liu ZH; Ding X; Ke RS
    Ir J Med Sci; 2022 Feb; 191(1):139-145. PubMed ID: 33547612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.
    Du Y; Chen Y; Wang F; Gu L
    Tumour Biol; 2016 Oct; 37(10):13557-13569. PubMed ID: 27468717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
    Li L; Mou YP; Wang YY; Wang HJ; Mou XZ
    Pathol Res Pract; 2019 Sep; 215(9):152511. PubMed ID: 31255331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer.
    Guo ZJ; Yang L; Qian F; Wang YX; Yu X; Ji CD; Cui W; Xiang DF; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Oncotarget; 2016 Apr; 7(15):20999-1012. PubMed ID: 27007162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
    Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
    Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
    Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
    PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
    Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
    Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.
    Yu L; Chen J; Liu Y; Zhang Z; Duan S
    Cancer Biomark; 2017 Dec; 21(1):105-116. PubMed ID: 29060929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
    Zhang J; Kong X; Shi Q; Zhao B
    Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.